**
Recent findings from a peer-reviewed study conducted by Mount Sinai researchers indicate that fetuses may be exposed to significantly higher levels of per- and polyfluoroalkyl substances (PFAS), commonly referred to as “forever chemicals,” than previously understood. The investigation involved an extensive analysis of umbilical cord blood samples, revealing a concerning array of 42 distinct PFAS compounds that pose potential health risks to newborns.
Expanded Analysis Uncovers New Compounds
Traditionally, testing of umbilical cord blood has focused on a restricted subset of PFAS, such as perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS), which are among the most frequently studied compounds. However, the latest study broadened the analytical approach, employing a non-targeted analysis that evaluated 120 samples of umbilical cord blood, previously known to contain only a few PFAS.
The research team, led by associate professor Shelley Liu at the Icahn School of Medicine, found that the total PFAS levels in the blood samples were markedly elevated, suggesting a far greater exposure to these chemicals than previously documented. Liu emphasised the significance of understanding this exposure, particularly during the critical developmental period for fetuses.
The Health Implications of PFAS Exposure
PFAS comprise a vast class of over 15,000 synthetic compounds, renowned for their water-, stain-, and grease-resistant properties. These chemicals have been implicated in various health concerns, including cancer, birth defects, compromised immune function, elevated cholesterol, and kidney disease. Their persistence in the environment has earned them the moniker “forever chemicals,” as they do not naturally degrade.
The dangers of PFAS exposure extend beyond the immediate health risks. A review encompassing 40 studies demonstrated that PFAS were detected in 30,000 umbilical cord blood samples, highlighting the widespread nature of this contamination. Elevated maternal PFAS levels have been associated with increased infant mortality rates, low birth weights, and the potential for obesity in later stages of life. Furthermore, fetal exposure to these chemicals is linked to long-term health issues, including cancer, neurological disorders, and cardiovascular diseases.
Regulatory Oversight Struggles to Keep Pace
The recent findings raise critical questions about regulatory frameworks that currently exist around PFAS testing and management. Historically, the methods employed by regulatory bodies, such as the US Environmental Protection Agency (EPA), have been inadequate in addressing the scope of PFAS contamination. The EPA’s testing protocols typically target only 30-40 PFAS compounds, neglecting the thousands identified by independent research.
The Mount Sinai study highlights the stark contrast between traditional testing methods and the new non-targeted approach, which revealed an additional 31 PFAS compounds not included in the EPA’s certified blood test for 53 substances. Despite improvements, Liu points out that the expanded list still falls short when considering the full spectrum of PFAS present in the environment and potentially impacting human health.
Future Research Directions
While the Mount Sinai study did not directly investigate specific health outcomes, the correlation between higher PFAS levels in blood and increased health risks is well-documented. The research team intends to delve deeper into the implications of their findings, aiming to better understand how prenatal exposure to a diverse array of PFAS compounds may affect long-term health outcomes for children.
David Andrews, acting chief science officer at the Environmental Working Group, underscores the urgency of these findings, stating that they illuminate the need for stricter health-protective regulations. The lack of adequate oversight has resulted in infants being born with a “pre-polluted” status, raising alarms about public health safeguards.
Why it Matters
The implications of this study extend far beyond academic interest; they underscore a pressing public health concern. As the prevalence of PFAS compounds continues to rise, understanding their impact on vulnerable populations, particularly fetuses, becomes increasingly critical. This research serves as a stark reminder of the urgent need for comprehensive regulatory measures to protect future generations from the potentially devastating effects of environmental contaminants. Without proactive intervention, we risk allowing these harmful chemicals to persist in our ecosystems and bodies, jeopardising both health and wellbeing.
